Godx

At GoDx®, we are committed to making it possible for all people to have access to our solutions. Our diagnostic tests don't require a laboratory, or a professional to interpret the results. Wherever you are and whenever you need, you can know your health. We will impact healthcare delivery in the United States through cutting-edge diagnostic innovation. Our focus is on addressing critical healthcare challenges, starting with gastrointestinal (GI) pathogen identification and antimicrobial resistance (AMR) detection at the point of care. Diarrheal diseases and antimicrobial resistance are not just global health issues; they significantly impact patient care, clinic operations, and healthcare costs in the U.S. GoDx® offers molecular diagnostics solutions that are fast, accurate, and cost-effective, designed to reduce the burdens faced by patients, clinicians, and administrators. By enabling rapid, point-of-care diagnostics, we are helping to: Improve Patient Outcomes: Faster diagnosis leads to timely and effective treatment, enhancing patient satisfaction and recovery. Support Healthcare Providers: Streamlined diagnostics improve clinician workflows, reduce overhead costs, and enable better resource allocation. Strengthen Public Health: Early identification of pathogens and AMR helps mitigate outbreaks and supports effective infection control measures. Since 2017, Dr. Kim and the GoDx® team have leveraged over a decade of diagnostic expertise to secure multiple federal and state grants, advancing solutions that align with national priorities for healthcare innovation and accessibility. Together, we are committed to delivering smarter diagnostics that empower communities, reduce healthcare disparities, and drive a more efficient healthcare system.